Standigm

Standigm is a workflow AI-driven drug discovery company. Standigm has proprietary AI platforms encompassing novel target identification to lead generation to generate commercially valuable drug pipelines. Founded in 2015, the company has established an early-stage drug discovery workflow AI to generate First-in-Class lead compounds within seven months. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactoryTM, and the automation effort has been expanding to the whole drug discovery process on the basis of Standigm AI platforms, including Standigm ASKTM for target discovery, Standigm BESTTM for lead design, and Standigm InsightTM for drug...

Artificial intelligence,drug discovery,active data parsing,bot modeling,biological interpretation,target identification,lead generation,machine learning,deep learning,drug repurposing,nlp,workflow ai,and ai drug discovery

Standigm operates in the Pharmaceutical manufacturing industry.

Standigm's revenue is 11m - 100m

Standigm has 11 - 50 employees.